New hope for babies: drug fights virus in the womb
NCT ID NCT01651585
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 29 times
Summary
This study tested the antiviral drug valacyclovir in 41 pregnant women whose unborn babies were infected with cytomegalovirus (CMV), a leading cause of birth defects. The goal was to see if treating the mother could lower the virus levels in the baby and reduce symptoms at birth. The approach aims to improve outcomes for infected fetuses by using a drug already known to be safe during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOETUSES INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Necker Enfants Malades
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.